Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Chondroitin vs Liraglutide: Chondroitin has the stronger overall evidence (5.5 vs 7.5/10); the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Chondroitin wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Probably helps
8 of 13 studies with measurable effects showed benefit.
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Shared outcomes (1)
Outcomes where both Chondroitin and Liraglutide have evidence — compare verdict strength side-by-side.
800-1200mg
With meals, Once daily or split into 2-3 doses
Chondroitin sulfate from bovine or marine sources
Prescription-only, clinician-titrated, subcutaneous once daily. Diabetes (Victoza): escalate 0.6 → 1.2 → 1.8 mg/day. Weight management (Saxenda): escalate weekly to 3.0 mg/day. DO NOT self-dose.
any
Subcutaneous once-daily injection (Victoza for diabetes, Saxenda for weight)
8-12 weeks
12+ weeks
6-24 months
Weeks to months
Months (titrated over weeks)
Months to years
Especially during dose escalation
Meta-analysis: chondroitin for osteoarthritis of the knee or hip
Annals of internal medicine (2007) · Meta analysis · n=3846
Large-scale, methodologically sound trials indicate that the symptomatic benefit of chondroitin is minimal or nonexistent.
The Safety and Efficacy of Glucosamine and/or Chondroitin in Humans: A Systematic Review
Nutrients (2025) · Systematic review · n=146
Of the 2013 articles screened, 146 studies were included in our review, with nearly 60% being randomized controlled trials and most conducted in Europe, Asia, or the U.S.
Systematic review and network meta-analysis on the efficacy and safety of parmacotherapy for hand osteoarthritis
PloS one (2024) · Meta analysis · n=3965
GCSB-5, a specific herbal complex that mainly regulate pain in hand osteoarthritis, showed the greatest reduction in pain [WMD = -13.00, 95% CI (-26.69, 0.69)].
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes (LEADER).
N Engl J Med (2016) · Rct · n=9340
Double-blind cardiovascular-outcomes RCT: 9,340 patients with type 2 diabetes and high cardiovascular risk, liraglutide (up to 1.8 mg/day) vs placebo, median follow-up 3.8 years
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (SCALE Obesity and Prediabetes).
N Engl J Med (2015) · Rct · n=3731
56-week double-blind RCT in 3,731 adults WITHOUT type 2 diabetes (BMI ≥30, or ≥27 with comorbidities), liraglutide 3.0 mg/day vs placebo plus lifestyle (2:1)
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.
JAMA (2015) · Rct · n=846
56-week double-blind RCT in 846 adults with overweight/obesity AND type 2 diabetes, liraglutide 3.0 mg vs 1.8 mg vs placebo (2:1:1)
Large meta-analyses show minimal to nonexistent benefits. Effects appear modest at best, with significant study heterogeneity. Combination with glucosamine may be more effective than chondroitin alone.
AI-estimated from published studies. Interpret as directional guidance.
Chondroitin has a higher evidence score (5.5/10 vs 7.5/10) and wins in 2 of 3 categories.
No known interactions between Chondroitin and Liraglutide have been documented in our database. However, always consult a healthcare provider before combining supplements.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.